坤集团(00924)发布公告，预期截至2025年12月31日止6个月将取得本公司拥有人应占亏损净额不超过约 2300万新加坡元，而2024年同期取得本公司拥有人应占纯利约20万新加坡元。基于当前可得资料，预期 本公司拥有人应占亏损净额主要归因于合约资产减值亏损增加。 ...

Core Viewpoint - Dianchi Waterworks (03768) anticipates a decrease in pre-tax profit for the year ending December 31, 2025, estimated between RMB 255.8 million and RMB 217.9 million, a reduction of RMB 58.6 million to RMB 96.5 million compared to the previous year [1] Financial Performance - The expected profit attributable to equity holders of the company for the same period is projected to be between RMB 212.3 million and RMB 180.8 million, down from approximately RMB 263.2 million for the year ending December 31, 2024, indicating a decrease of RMB 50.9 million to RMB 82.4 million [1] Reasons for Profit Decrease - The decline in profit is primarily attributed to the sale of a subsidiary in 2024, which will lead to a reduction in revenue for 2025, resulting in a year-on-year profit decrease [1] - An increase in expected credit impairment losses for 2025 is also anticipated [1] - Additionally, a reduction in engineering investments is expected to contribute to a year-on-year decline in profits from the engineering construction business [1]

Core Viewpoint - The company has successfully obtained medical device registration for its BioCyte series flow cytometers in Malaysia, marking a significant step in expanding its presence in the Southeast Asian market [1] Group 1: Product Development and Approval - The BioCyte series flow cytometers developed by the company's subsidiary, China Bio (Suzhou) Medical Technology Co., Ltd., have passed the Malaysian Medical Device Authority's review [1] - The registration number for the medical device is IVDA9463526–225393, indicating that the product is now legally qualified for sale and use in Malaysia [1] Group 2: Market Expansion and Strategy - The approval allows the company to expand its market reach in Southeast Asia and enhance its brand influence and market coverage internationally [1] - The product will be marketed through the local authorized representative, TRUST DIAGNOSTICS SDN BHD, facilitating the company's market entry strategy [1] Group 3: Technology Application - Flow cytometry technology is widely used in clinical diagnostics and research, providing technical support for disease diagnosis, immunology research, and drug development [1] - The BioCyte series has already been applied in the domestic market due to its stable performance and accuracy in detection [1]

圆通国际快递(06123)发布公告，与2024年相应年度相比，预期本集团于截至2025年12月31日止年度将 取得净亏损增加。 本集团预期于截至2025年12月31日止年度将取得净亏损介乎约1.45亿港元至1.54亿港元(截至2024年12月 31日止年度：净亏损约4200万港元)。净亏损增加的主要原因包括：(i)由于部分主要经济体关税政策波 动，带来跨境贸易的不确定性增加，国际货运市场尤其是国际空运市场的需求、价格均出现较大波动， 导致货运业务利润下降;(ii)为集中资源发展核心业务，公司主动优化业务结构，战略性地缩减了部分低 毛利率或回款周期较长的非核心业务，导致整体收入及毛利减少;(iii)为深化推进国际化发展战略，构建 全球快递枢纽设施和运营网络，实现"中国联世界，世界联世界"，打造安全、畅通、便捷、高效、可持 续、自主、可控的物流供应链体系，并推进人工智能等前沿技术应用，全方位提升核心竞争力，于截至 2025年12月31日止年度内本集团持续加大国际化人才的引进与培养，针对重点区域和国家、关键市场等 构建物流枢纽，增强对物流核心基础设施和资源的掌控力，并全面推动数字化向智能化转型升级，强化 技术创新驱 ...

华润饮料(02460)发布公告，吴霞女士因其他工作安排，自2026年2月13日起辞任本公司首席财务官。 董事会进一步宣布，黄鹄女士自2026年2月13日起获委任为首席财务官。 ...

Group 1 - The company, Country Garden (02007), announced the issuance of a total of 169 million shares due to the conversion of zero-coupon mandatory convertible bonds, which will mature 78 months after June 30, 2025 [1]

Core Viewpoint - China Merchants China Fund (00133) announced that its unaudited net asset value per share as of January 31, 2026, is $5.495 (42.96 HKD) [1] Summary by Category - **Company Performance** - The unaudited net asset value per share is reported at $5.495 [1] - The equivalent value in Hong Kong dollars is 42.96 HKD [1]

Group 1 - The core point of the article is that China Nuclear Engineering Corporation (601611.SH) announced its financial performance, reporting a total of 3.393 billion yuan in new contracts signed and 7.690 billion yuan in cumulative operating revenue as of January 2026 [1] Group 2 - The company has achieved a significant milestone with new contracts amounting to 3.393 billion yuan [1] - The cumulative operating revenue reached 7.690 billion yuan, indicating the company's ongoing business activities and financial health [1]

（原标题：FUTURE BRIGHT(00703)附属拟租赁澳门物业） 智通财经APP讯，FUTURE BRIGHT(00703)发布公告，于2026年2月13日，本公司全资附属公司骏盈(作 为商户)订立该协议，倘该协议由新濠天地度假村有限公司(营运商)加签，营运商同意授予骏盈使用该物 业(澳门新濠天地新濠大道F110A铺)用作经营日式餐厅的权利，租金为(i)每月基本费用或(ii)每月营业额 费用(以较高者为准)。 本集团自2009年起于该物业所在地以"江户日本料理"品牌经营日式餐厅，过往表现大体上令人满意。鉴 于访澳旅客水平持续上升及"江户日本料理"于澳门品牌声誉良好，本公司计划于该物业继续经营该餐 厅。目前，本公司于澳门共有3间"江户日本料理"餐厅。董事会认为于该物业经营该餐厅有助于为本集 团带来稳定的营业额及盈利。 ...

（原标题：嘉文世纪投资公司(00612)1月末每股综合资产净值约为0.30港元） 智通财经APP讯，嘉文世纪投资公司(00612)公布，于2026年1月31日，公司的未经审核的每股综合资产 净值约为0.30港元。 ...